AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing
We’re invested in health to develop the next generation of medical innovations.
From early-stage seed investment through to expansion capital, we support life science companies from proof-of-concept through to commercialisation.
active portfolio companies
Investors and Venture Partners spanning Australia, New Zealand, United States and the United Kingdom
Brandon Capital LLC
1 Letterman Ave, Suite C3-330
San Francisco, CA 94129
Phone +61 3 9657 0700
The Gridiron Building, 1 Pancras Square
Kings Cross, London N1C 4AG
United Kingdom